Chungbuk National University is one of ten Flagship Korean National Universities. It takes its name, Chungbuk, from the common abbreviated form of the province's Korean name Chungcheongbuk-do.

During the past decade, Chungbuk National University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Chungbuk National University" are "Obesity" (2 trials) and "Diabetes" (1 trials). Many other conditions were trialed in "Chungbuk National University" in a lesser frequency.

Most popular intervention types in "Chungbuk National University" are "Device" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Integrated Diabetes Management Protocol" (1 trials), "Standard Diabetes Management Protocol" (1 trials), "real tDCS" (1 trials), "sham tDCS" (1 trials) and "tDCS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chungbuk National University" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Chungbuk National University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Chungbuk National University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Chungbuk National University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".